Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Nio

Showing results (1-10 of 194) with videos related to

Pageof 20
Sort By:
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|September 1, 1970
[Studies on the cells producing an antitumor agent]Y Nio
Nihon Geka Gakkai Zasshi|September 1, 1989
[Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer]Y Nio, T Tobe
Nihon Geka Gakkai Zasshi|July 1, 1997
[Newly-developing therapies of pancreatic cancer--immunotherapy, gene therapy, differentiation therapy, endocrine therapy and others]Y Nio, K Tamura
Journal of Clinical & Laboratory Immunology|May 1, 1989
Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytomaY Nio, K Ohgaki, T Tobe
Zeitschrift Fur Gastroenterologie|August 1, 1987
Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer diseaseG N Tytgat, C Y Nio
Cancer|June 15, 1992
The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytesY Mizutani, Y Nio, O Yoshida
The Journal of Urology|November 1, 1992
Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cellsY Mizutani, Y Nio, O Yoshida
Ryoikibetsu Shokogun Shirizu|January 1, 1996
[Emphysematous cholecystitis]H Nagami, Y Nio, K Tamura
Anti-Cancer Drugs|December 13, 1997
5-Fluorouracil + cisplatin + mitomycin C is a relatively most effective combination against xenograft lines of human colorectal cancerK Kawabata, Y Nio, M Imamura
Bailliere'S Clinical Gastroenterology|October 1, 1987
The medical therapy of reflux oesophagitisG N Tytgat, C Y Nio
Pageof 20

Showing results (1-10 of 194) with videos related to

Sort By:
Pageof 20
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|September 1, 1970
[Studies on the cells producing an antitumor agent]Y Nio
Nihon Geka Gakkai Zasshi|September 1, 1989
[Immunity of gut-associated lymphoid tissue and the role of the oral immunotherapy in multi-disciplinary treatment of the digestive organ cancer]Y Nio, T Tobe
Nihon Geka Gakkai Zasshi|July 1, 1997
[Newly-developing therapies of pancreatic cancer--immunotherapy, gene therapy, differentiation therapy, endocrine therapy and others]Y Nio, K Tamura
Journal of Clinical & Laboratory Immunology|May 1, 1989
Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytomaY Nio, K Ohgaki, T Tobe
Zeitschrift Fur Gastroenterologie|August 1, 1987
Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer diseaseG N Tytgat, C Y Nio
Cancer|June 15, 1992
The streptococcal preparation OK-432 specifically augments the susceptibility of human urinary bladder tumor cells to autologous peripheral blood lymphocytesY Mizutani, Y Nio, O Yoshida
The Journal of Urology|November 1, 1992
Effect of PSK and its subfractions on peripheral blood lymphocytes mediated cytotoxicity against urinary bladder tumor cellsY Mizutani, Y Nio, O Yoshida
Ryoikibetsu Shokogun Shirizu|January 1, 1996
[Emphysematous cholecystitis]H Nagami, Y Nio, K Tamura
Anti-Cancer Drugs|December 13, 1997
5-Fluorouracil + cisplatin + mitomycin C is a relatively most effective combination against xenograft lines of human colorectal cancerK Kawabata, Y Nio, M Imamura
Bailliere'S Clinical Gastroenterology|October 1, 1987
The medical therapy of reflux oesophagitisG N Tytgat, C Y Nio
Pageof 20